XML 28 R16.htm IDEA: XBRL DOCUMENT v3.19.1
LEASES
3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
Lessee, Operating Leases [Text Block]
NOTE 9. LEASES
 
As described further in “Note 2. Summary of Significant Accounting Policies”, the Company adopted Topic 842 as of January 1, 2019. Prior period amounts have not been adjusted and continue to be reported in accordance with its historic accounting under ASU Topic 840- Leases (Topic 840).
 
Facilities Leases
 
The Company has evaluated the following facility leases and determined that, effective upon the adoption of Topic 842, they were all operating leases. Operating lease right-of-use assets and liabilities were recognized as of January 1, 2019 based on the present value of the remaining lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company utilized a third party in determining an incremental borrowing rate based on the information available as of the adoption date of Topic 842 to obtain the present value of lease payments. The Company’s lease terms may include options to extend or terminate the lease which are included in the lease term when it is reasonably certain that it will exercise any such options. Lease expense is recognized on a straight-line basis over the expected lease term. The Company elected not to apply the recognition requirements of Topic 842 for short-term leases that have a lease term of 12 months or less.
 
Tampa Lease
 
In December 2014, the Company commenced a five-year non-cancellable operating lease with the University of South Florida Research Foundation for a 5,115 square foot facility located in Tampa, Florida. The facility is part of the University of South Florida research park and is used as the Company’s research and development facilities. The Company has the option to extend the lease term of this facility for an additional five-year period on the same terms and conditions, except that the base rent for the renewal term will be increased in accordance with the applicable consumer price index.
 
In April 2015, the Company amended the original lease agreement to increase the rentable space to 6,043 square feet. In September 2016, the Company further increased the rentable space to 8,673 square feet. The per square foot cost and term of the lease were unchanged, and rent payments are approximately $20,000 per month. The lease expires in December 2019.
 
San Carlos Lease
 
On August 4, 2016, the Company entered into an agreement to lease 8,733 square feet in San Carlos, California. The term of the lease is 54 months subsequent to the commencement date and will expire in April 2021. Monthly lease payments are approximately $38,000.
 
On April 28, 2017, the Company entered into a sublease agreement with Teradata US, Inc., pursuant to which the Company agreed to sublease certain office space located adjacent to the Company's headquarters for approximately $26,000 per month. The space consists of approximately 11,449 rentable square feet in the building located in San Carlos, California. The sublease for this space expired on October 31, 2018. Monthly lease payments were approximately $26,000.
 
On October 19, 2018, the Company entered into an agreement to lease 12,322 square feet of office space located adjacent to the Company's headquarters in San Carlos, California. This lease replaces the sublease of 11,449 square feet of office space in the same facility that expired on October 31, 2018. The term of the lease is 30 months subsequent to the commencement date, November 1, 2018, and will expire in April 2021. Monthly lease payments are approximately $59,000, subject to an annual increase of 3%. 
 
New York Lease
 
The Company leased office space in New York for a monthly rental of approximately $18,000 a month from January 2017 through July 2017. On June 5, 2017, the Company entered into an agreement whereby the Company will lease office space from August 1, 2017 to July 31, 2018, for approximately $9,000 a month. On April 20, 2018, the Company entered into an agreement to extend the lease term to January 31, 2019 for approximately $7,000 a month. On November 2, 2018, the Company entered into an agreement to extend the lease term to July 31, 2019 for approximately $4,000 a month.
 
Manufacturing Contracts
 
The Company uses contract manufacturing organizations (collectively the “CMOs” and each a “CMO”) to manufacture and supply TILs for clinical and commercial purposes. The CMO contractual obligations consist of the use of manufacturing facilities and minimum fixed commitment fees, such as personnel, general support fees, and minimum production or material fees. In addition to the minimum fixed commitment fees, the CMO contractual obligations include variable costs such as production and material costs in excess of the minimum quantity specified in each CMO agreement. During the term of each CMO agreement, the Company has access to and control of the use of a dedicated suite in each of the CMOs’ facilities for manufacturing activities. In conjunction with the adoption of Topic 842 on January 1, 2019, the Company reevaluated all of its material contracts it has, to determine whether they contain a lease under the current lease guidance Topic 840. An arrangement is considered a lease or contains a lease if an underlying asset is explicitly or implicitly identified and use of the asset is controlled by the customer. Based on this evaluation, the Company concluded that all of its contracts with CMOs contained embedded operating leases because the suites used for its production are implicitly identified, is only used by the Company exclusively during the contractual term of the arrangements, and the CMOs have no substantive contractual rights to substitute the facilities used by the Company. Further, the Company controls the use of the facilities by obtaining all of the economic benefits from the use of the facilities and direct the use of the facilities throughout the period of use. The terms of the CMO contracts include options to terminate the lease with an advance notice of five to six months. The termination clauses and extension clauses are included in the calculation of the lease term for each of the CMOs when it is reasonably certain that it will not exercise such options.
 
The guidance requires the Company to first identify a lease deliverable and non-lease deliverable included in the arrangements, and then allocate the fixed contractual consideration to the lease deliverable(s) and the non-lease deliverable(s) on a relative standalone selling price basis to determine the amount of operating lease right-of-use assets and liabilities. The Company identified the use of a dedicated suite as a single lease deliverable, and related labor services as a single non-lease deliverable in each of the CMO arrangements. Judgment is required to determine the relative standalone selling price of each deliverable as the observable standalone selling prices are not readily available. Therefore, management used estimates and assumptions in determining relative standalone selling price of lease of a suite and labor service using information that includes market and other observable inputs to the extent possible.
 
The Company leases certain furniture and equipment that has a lease term of 12 months or less. Since the commencement date does not include an option to purchase the underlying asset, the Company elected not to apply the recognition requirements of Topic 842 for short-term leases, however, the lease costs that pertain to the short-term leases are disclosed in the components of lease costs table below.
 
The balance sheet classification of the Company’s right-of-use asset and lease liabilities was as follows:
 
 
 
March 31, 2019
 
 
 
 
 
Operating lease right-of-use assets
 
$
9,957
 
Operating lease liabilities
 
 
 
 
     Current portion included in current liabilities
 
 
6,059
 
     long-term portion included in non-current liabilities
 
 
4,380
 
        Total Operating lease liabilities
 
$
10,439
 
 
The components of lease expenses, which were included in Total expenses in the Company’s consolidated statement of operations, were as follows:
 
 
 
For the Three Months Ended
March 31, 2019
 
 
 
 
 
Operating lease cost
 
$
1,594
 
Variable lease cost
 
 
896
 
Short-term lease cost
 
 
19
 
    Total lease cost
 
 
2,509
 
 
Variable lease cost is determined based on performance or usage in accordance with the contractual agreements, and not based on an index or rate.
 
Cash paid for amounts included in the measurement of lease liabilities for the three months ended March 31, 2019 was $1.4 million and were included in Net cash provided by operating activities in its consolidated statement of cash flows. Upon the adoption of Topic 842 on January 1, 2019, the Company increased noncash balances of operating lease right-of-use assets and operating lease liabilities by $10.4 million and $10.7 million, respectively. During the three months ended March 31, 2019, the Company additionally increased noncash balance of operating lease right-of-use assets and operating lease liability by $1.0 million as a result of lease modifications.
 
As of March 31, 2019, the maturities of the Company’s operating lease liabilities were as follows (in thousands):
 
 
 
Facility leases
 
 
CMO embedded leases
 
 
Total
 
Remainder of 2019
 
$
1,066
 
 
$
3,975
 
 
$
5,041
 
2020
 
 
1,223
 
 
 
3,366
 
 
 
4,589
 
2021
 
 
419
 
 
 
994
 
 
 
1,413
 
2022
 
 
-
 
 
 
144
 
 
 
144
 
2023
 
 
-
 
 
 
-
 
 
 
-
 
Thereafter
 
 
-
 
 
 
-
 
 
 
-
 
    Total lease payments
 
$
2,708
 
 
$
8,479
 
 
$
11,187
 
Less:  Present value adjustment
 
 
(189
)
 
 
(559
)
 
 
(748
)
           Operating lease liabilities
 
$
2,519
 
 
$
7,920
 
 
$
10,439
 
 
Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used its incremental borrowing rate based on the information available at the date of adoption of Topic 842. As of March 31, 2019, the weighted average remaining lease term is 1.86 years and the weighted average discount rate used to determine the operating lease liabilities was 8.4%.
 
Disclosures related to periods prior to adoption of Topic 842
 
As required, the following disclosure is provided for periods prior to adoption. Minimum lease commitments as of December 31, 2018 that have initial or remaining lease terms in excess of one year are as follows:
 
 
 
Facility leases
 
 
CMO embedded leases
 
 
Total
 
2019
 
$
1,373
 
 
$
5,088
 
 
$
6,461
 
2020
 
 
1,223
 
 
 
3,366
 
 
 
4,589
 
2021
 
 
418
 
 
 
994
 
 
 
1,412
 
2022
 
 
-
 
 
 
144
 
 
 
144
 
2023
 
 
-
 
 
 
-
 
 
 
-
 
Thereafter
 
 
-
 
 
 
-
 
 
 
-
 
    Total lease payments
 
$
3,014
 
 
$
9,592
 
 
$
12,606